首页

基本信息

628
31
12
3.9(29)

子类别与细分类别

交易类型

出售

产品名称

Liraglutide

规格参数

  • 制剂类型: 皮下注射(每日一次)
  • IUPAC Name: (2S)-5-[[(5S)-5-[[(2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S)-2-[[(2S,3R)-2-[[(2S)-2-[[(2S,3R)-2-[[2-[[(2S)-2-[[(2S)-2-[[(2S)-2-amino-3-(1H-imidazol-5-yl)propanoyl]amino]propanoyl]amino]-4-car
  • EC Number: 810-818-7
  • Molecular Weight: 3751
  • Chemical Formula: C172H265N43O51
  • CAS Number: 204656-20-2

其他信息

补充描述:

Suzhou Pharmaserve Technology Co., Ltd., established in 2019 in Suzhou Industrial Park, is a trading company specializing in peptide-based active pharmaceutical ingredients, including Semaglutide, Liraglutide, Tirzepatide, Octreotide Acetate, Cetrorelix Acetate, Ganirelix Acetate, Desmopressin, Oxytocin, Carbetocin, and Atosiban Acetate, alongside natural extracts, finished dosage forms, API equipment, and food additives. Operating in compliance with GMP principles and exporting essentially 100% of its output, the company supplies distributors, wholesalers, and pharmaceutical companies across more than 20 countries including the US, Mexico, Brazil, Turkey, and Middle Eastern markets, supported by a manufacturing facility with over 100 staff and a CDMO service offering. It emphasizes its global B2B reach, certification and regulatory compliance, and reliable, prompt logistics as key strengths, though it notes it does not yet hold patents of its own.
筛选:
排序方式:

    暂无评论。

匹配的产品和服务

基于贸易类型、类别、规格和价格范围的B2B匹配

相似产品和服务

与您正在查看的内容相关的产品和服务

其他人也浏览了

查看过此产品的人也浏览了其他产品和服务